Pam Belluck
Posts
Helping Stroke Patients Regain Movement in their Hands
The results of an innovative study suggest electrical stimulation of the spinal cord could eventually help some of the many people disabled by strokes.
New Lawsuit Challenges State Bans on Abortion Pills
The case, brought by GenBioPro, a company that makes one of two abortion drugs, argues that it is unconstitutional for a state to bar access...
Long Covid Is Keeping Significant Numbers of People Out of Work, Study Finds
An analysis of workers’ compensation claims in New York found that 71 percent of claimants with long Covid needed continuing medical treatment or were unable...
The Father of the Abortion Pill
The 96-year-old scientist who came up with an idea for an “unpregnancy pill” decades ago has led an eventful life, from his teenage days in...
FDA Approves, Leqembi, New Treatment for Early Alzheimer’s
The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more...
CVS and Walgreens Plan to Offer Abortion Pills Where Abortion Is Legal
The two chains said they would begin the certification process under a new F.D.A. regulation that will allow retail pharmacies to dispense the prescription pills...
Abortion Pills Can Now Be Offered at Retail Pharmacies, F.D.A. Says
Mifepristone, the first of two drugs in medication abortions, previously had to be dispensed only by clinics, doctors or a few mail-order pharmacies. Now, if...
Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen
The report said the F.D.A.’s approval process for Aduhelm was “rife with irregularities” and criticized Biogen for setting an “unjustifiably high price.”
Alzheimer’s Drug May Benefit Some Patients, New Data Shows
The drug, lecanemab, made by Eisai and Biogen, also carried risks of brain swelling and bleeding and should be studied further, a report of the...
Paxlovid May Reduce Risk of Long Covid in Eligible Patients, Study Finds
The research looked at patients who qualified for the antiviral through age or health conditions. Those who took it shortly after infection were 26 percent...